These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma cell myeloma with double M bands on Serum protein electrophoresis: A diagnostic conundrum? Misra S; Singh A; Kumar V J Cancer Res Ther; 2024 Apr; 20(3):1026-1028. PubMed ID: 38102909 [TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Murray DL; Puig N; Kristinsson S; Usmani SZ; Dispenzieri A; Bianchi G; Kumar S; Chng WJ; Hajek R; Paiva B; Waage A; Rajkumar SV; Durie B Blood Cancer J; 2021 Feb; 11(2):24. PubMed ID: 33563895 [TBL] [Abstract][Full Text] [Related]
4. [Clinical features and prognosis of patients with primary light chain deposition disease]. Wang JN; Feng J; Cao XX; Duan MH; Zhang L; Zhou DB; Li J Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):253-256. PubMed ID: 28395454 [No Abstract] [Full Text] [Related]
7. The impact on early diagnosis and survival outcome of M-protein screening-driven diagnostic approach to multiple myeloma in China: a cohort study. Li J; Wang Y; Liu P J Cancer; 2019; 10(20):4807-4813. PubMed ID: 31598151 [No Abstract] [Full Text] [Related]
8. Serum Protein Electrophoresis and Immunofixation Electrophoresis Detection in Multiple Myeloma. Zhu S; Li W; Lin M; Li T J Coll Physicians Surg Pak; 2021 Jul; 31(7):864-867. PubMed ID: 34271795 [TBL] [Abstract][Full Text] [Related]
9. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies. Singh G J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling. Wu V; Moshier E; Leng S; Barlogie B; Cho HJ; Jagannath S; Madduri D; Mazumdar M; Parekh S; Chari A Blood Adv; 2018 Jun; 2(12):1470-1479. PubMed ID: 29945937 [TBL] [Abstract][Full Text] [Related]
11. [5th International Symposium on clinical applications of serum free light chain analysis]. Decaux O Rev Med Interne; 2009 Jan; 30(1):96-100. PubMed ID: 19054596 [No Abstract] [Full Text] [Related]
12. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease. Levinson SS Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046 [TBL] [Abstract][Full Text] [Related]
13. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias. Mayo MM; Johns GS Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223 [TBL] [Abstract][Full Text] [Related]
14. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies. Tate JR; Graziani MS; Mollee P; Merlini G Clin Chem Lab Med; 2016 Jun; 54(6):899-905. PubMed ID: 27107838 [No Abstract] [Full Text] [Related]
15. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias. Willrich MA; Katzmann JA Clin Chem Lab Med; 2016 Jun; 54(6):907-19. PubMed ID: 26509779 [TBL] [Abstract][Full Text] [Related]
16. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point. Pretorius CJ Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893 [TBL] [Abstract][Full Text] [Related]